Journals / Dicle Tıp Dergisi / 2010 / Cilt: 37 - Sayı: 4

Kolerektal kanserli hastalarda serum adipositokin düzeyleri

Serum adipocytokine levels in patients with colorectal cancer

Pages
321–325
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to investigate the possible prognostic value of leptin and resistin in clinical practice of patients with colorectal cancers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Adipose tissue, besides its main function as an energy storage depot, is currently considered an endocrine organ that secretes several self-produced cytokines.
📊
Key Findings & Data:Materials and methods: The body mass index (BMI) and values of leptin and resistin in blood at diagnosis were measured in 12 colorectal cancer patients in pre- and post-operational periods and in 12 age- and sex-matched controls.
💡
Conclusion & Impact:Further studies are needed to investigate the possible prognostic value of leptin and resistin in clinical practice of patients with colorectal cancers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Adipose tissue, besides its main function as an energy storage depot, is currently considered an endocrine organ that secretes several self-produced cytokines. Leptin and resistin play an important role in energy homeostasis, glucose, lipid metabolism and regulation of body weight. The aim of the current study was to determine the concentration of leptin and resistin in pre-operational and post-operational periods of patients diagnosed as colorectal cancer. Materials and methods: The body mass index (BMI) and values of leptin and resistin in blood at diagnosis were measured in 12 colorectal cancer patients in pre- and post-operational periods and in 12 age- and sex-matched controls. Serum leptin and resistin concentrations were measured by ELISA method. Results: Decreased leptin (1.95±0.62 ng/ml) and resistin (4.32±1.83 ng/ml) levels were found in pre-operational group compared with the control group (leptin: 6.12±0.82 ng/ml; resistin: 10.75±1.46 ng/ml) (p<0.001, p<0.001, respectively). Leptin levels were increased in post-operational period (3.29±0.69 ng/ml) compared with the pre-operational period (p<0.001). However, no difference was found in post-operative resistin levels (4.75±1.33 ng/ml) compared with pre-operative period (p>0.05). Conclusion: We conclude that serum concentration of leptin and resistin may have a role in patients with colorectal cancers. Further studies are needed to investigate the possible prognostic value of leptin and resistin in clinical practice of patients with colorectal cancers.

Özet

Amaç: Yağ dokusu, bir enerji deposu olan ana işlevinin yanında, bazı sitokinler salgılayarak bir endokrin organ olarak kabul edilir. Leptin ve rezistin, enerji homeostazisinde, glikoz, lipid metabolizmasında ve vücut ağırlığının düzenlenmesinde önemli bir rol oynamaktadır. Bu çalışmanın amacı, kolorektal kanserli hastalarda operasyon öncesi ve operasyon sonrası dönemlerde leptin ve rezistin konsantrasyonlarının belirlenmesidir. Gereç ve yöntem: Toplam 12 kolorektal kanserli hastada ameliyet öncesi ve sonrası dönemde ve yaş ve cinsiyet uyumlu 12 kişiden oluşan kontrol grubunda vücut kitle indeksi (VKİ) ve kan örneklerinde leptin ve rezistin düzeyleri ölçüldü. Serum leptin ve rezistin konsantrasyonları ELISA ile yöntemi ile ölçüldü. Bulgular: Operasyon öncesi grup (leptin: 1.95±0.62 ng/ml; resistin 4.32±1.83 ng/ml) kontrol grubuna (leptin: 6.12±0.82 ng/ml; resistin: 10.75±1.46 ng/ml) göre karşılaştırıldığında leptin ve rezistin düzeylerinde azalma gözlemlendi (sırasıyla, p 0.05). Sonuç: Çalışmamızda serum leptin ve rezistin konsantrasyonlarının kolorektal kanserde önemli rol oynayabileceği sonucuna varıldı. Ayrıca leptinin muhtemelen prognostik değeri klinikte faydalı olabilir ancak daha fazla araştırmanın yapılması gereklidir.

🔖

Cite This Article

USLU, S., ERKASAP, S., ÖZÇELİK, E., KARA, M., ERKASAP, N. (2010). Kolerektal kanserli hastalarda serum adipositokin düzeyleri. Dicle Tıp Dergisi, Cilt: 37 - Sayı: 4, 321–325. https://ajindex.com/articles/349187

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Caan BJ, Coates AO, Slattery ML, Potter JD, Qusenberr CP, Edwards SM. Body size and the risk of colon cancer in large case-control study. Int J Obes 1998;22:178-84
  2. Housa D, Housava J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiol Res 2006;55:233-44
  3. Wolf I, Sadetzki S, Kanety H, et al. Adiponectin, ghrelin and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006;106:966-73
  4. Baratta M. Leptin from a signal of adiposity to a hormone mediator in peripheral tissues. Med Sci Monit 2002;8:282–92
  5. Friedman JM, Halaas J. Leptin and the regulation of body weight in mammals. Nature 1998;22:763–70
  6. Ukkola O. Resistin a mediator of obesity associated insulin resistance or an innocent bystander. Eur J Endocrinol 2002;147:571–4
  7. Kumor A, Daniel P, Pietruczuk M, Małecka PE. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009;24:275–81
  8. Arpaci F, Yılmaz MI, Ozet A, ve ark. Low serum leptin level in colon cancer patients without significant weight loss. Tumori 2002;88:147-9
  9. Simone ND, Nicuolo FD, Sanguinetti M, et al. Resistin regulates human choriocarcinoma cell invasive behavior and endothelial cell angiogenic processes. J Endocrinol 2006;189:691-9
  10. Karapanagiotou EM, Tsochatzis EA, Dilana KD, Tourkantonis I, Gratsias I, Syrigos KN. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer 2008;61:391-7
  11. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511—25
  12. Nakajima TE, Yamada Y, Hamano T, et al. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010;101:1286-91
  13. Bolukbas F, Kilic H, Bolukbas C, ve ark. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004;4:29-33
  14. Simons JP, Schols AM, Campfirld L.A et al. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond) 1997;93:273–7
  15. Wallace AM, Sattar N, McMillan DC. Effect of weight loss and the inflammatory response on leptin concentration in gastrointestinal cancer patients. Clin Cancer Res 1998;4:2977–9
  16. Hardwick JC, Van Der Brink GR, Offerhause GJ. Leptin is